Routy et al.71 showed that fecal microbiota transplantation (FMT) from cancer patients who responded to anti-PD-1 into germ-free or antibiotic-treated mice established the anti-tumour effects of PD-1 blockade, whereas FMT from non-responding patients failed to do so. The gene discussed is PDCD1; the disease is cancer.